Skip to main content

Table 1 The intermission of RT and days of RT without carboplatin

From: Concurrent hyperfractionated chemoradiotherapy for head and neck squamous cell carcinoma: the prognostic impact of the overall treatment time and completion rates of chemotherapy

Days Intermission days of RT n (%) Days of RT without carboplatin n (%)
0 37 (54) 27 (39)
1–5 8 (12) 13 (19)
6–10 12 (7) 13 (19)
11–20 11 (16) 13 (19)
21– 1 (1) 3 (4)